Andrew Sinclair
CIK 1762451 · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.09M
Companies
6
Total Filings
34
Lifetime Open-Market Net
$33.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Director | 133,318 | $8.20 | $1.09M | $14.00M | 11 | 2026-06-23 |
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 1,201,507 | $53.01 | $63.69M | $5.50M | 11 | 2026-05-18 |
| NCNA | Director | — | $1.29 | — | $0 | 1 | 2024-08-23 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $4.05M | 7 | 2022-07-01 |
| Verona Pharma plc (VRNA) Delisted | Director | — | $106.91 | — | $0 | 1 | 2021-08-10 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 6,969,272 | — | — | $10.23M | 3 | 2019-10-29 |
Recent Filings · Page 2 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-14 | SOLENO THERAPEUTICS INC (SLNO) Delisted | — | — | $0 | EDGAR |
| 2022-10-14 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-01 | Sierra Oncology, Inc. (SRRA) Delisted | Disp (D) | −1,314,127 | -$72.28M | EDGAR |
| 2022-06-03 | ACET | Grant (A) | — | $0 | EDGAR |
| 2022-03-31 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Buy (P) | +7,720,000 | $0 | EDGAR |
| 2022-02-01 | Sierra Oncology, Inc. (SRRA) Delisted | Mixed | +437,471 | $7.84M | EDGAR |
| 2021-12-13 | ACET | Buy (P) | +500,000 | $7.00M | EDGAR |
| 2021-12-10 | ACET | Buy (P) | +500,000 | $7.00M | EDGAR |
| 2021-08-10 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.